Newsroom
This page contains up-to-date information on the global intellectual property proceedings relating to CRISPR-Cas9 gene editing, as well as relevant press coverage and answers to frequently asked questions.
US Legal Events
U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
July 2, 2019
FAQ
We answer some commonly asked questions on the CRISPR-Cas9 intellectual property situation globally.
Learn more
International Patent Landscape
“Europe: Legal issues lead to invalidation of 4th Broad EP patent”
May 17, 2019
European Patent Office (EPO) awarded the Doudna-Charpentier team a broad CRISPR-Cas9 patent (EP Patent No. 3 401 400)
April 3, 2019
“Europe: Legal issues lead to invalidation of second Broad patent; significant reduction in scope of third Broad patent”
February 15, 2019
